Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update

(2008) Emmet B. Keeffe et al.   Clinical Gastroenterology and Hepatology

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

(2008) Carl J. Baldick et al.   HEPATOLOGY

Use of the Novel INNO-LiPA Line Probe Assay for Detection of Hepatitis B Virus Variants That Confer Resistance to Entecavir Therapy

(2008) R. Jardi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

(2008) Carl J. Baldick et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Chronic Hepatitis B — New Goals, New Treatment

(2008) Ching-Lung Lai et al.   NEW ENGLAND JOURNAL OF MEDICINE

Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

(2007) Jean–Michel Pawlotsky et al.   GASTROENTEROLOGY